Amazon.com/
AMZN
Bristol Myers Squibb / BMY
Comcast/ CMOSA
Exxon Mobil/ XOM
Fairfax Financial Holdings/ FREHF
Flutter
Entertainment/ FLUT
Madison Square Garden Sports/
MSGS
SL Green Reality
SLG
Visa/V
Walt Disney/ DIS
Article Title: "Amazon and 9 More Stocks to Buy for 2026"
I own MSGS ($237.44 Friday). One of 2 stocks in my hedge basket. Was thinking of unloading it after a near $40 price gain since August. Guess I'll hang around longer if Barron's wants to tout it.
Comments
CMCSA is on my watch list, primarily as an broadband infrastructure play. If/when it crosses a 5% yield I plan to start nibbling if I have cash available...
Maybe these recommended high dividend stocks from the same issue of Barron's might interest you?
AbbVie / ABBV
Chevron / CVX
Coca-Cola / KO
Exxon Mobil / XOM
FedEx / FDX
J.M. Smucker / SJM
Northern Trust / NTRS
Pitney Bowes / PBI
Procter & Gamble / PG
Qualcomm / QCOM
Article title: 10 High-Yielding Dividend Stocks to Buy for 2026
We aim to please!
I am also looking at AVGO. I previously owned BMY, CMCSA, SLG, KO, XOM, ABBV & V. Many I sold when they got stretched. Some have pulled back a lot, like CMCSA.
Will look over the whole bunch for stocks that meet my criteria. On a quick look, I like V (on a pullback), BMY, AVGO and KO. At this point in time, I really have to like a stock, or I just add to existing funds.
Re Barron's - better than a 500 batting average. But some of their picks take years to pan out and may drop a lot farther before turning up. Tries anyone's patience.
dAnd yet, I like to keep the Zurich Axioms in mind. Some may say they're worthless because they're not "actionable." But is investing an Art or a Science? The answer is, YES. "Zurich" is a set of broad principles, not a particular recipe for Veal Parmesan. I easily connect with "Zurich." An investor must engage their intellect, intuition, memory and peculiar predilections. ("You keep telling me to buy Real Estate. Every time I do that, I get burned! So, no more.")
I hear that. I bought ADBE not long ago and am still regretting it. But, I imagine it will have its day and I will recoup, or even gain. It only makes up .14% of my portfolio, but still irks me.
Don't hesitate to post "lists", we are all adults here, with few exceptions. lol
BTW - I bought RIO on Barron's advice roughly 5-6 years ago and did quite well with it. I found it a better stock for trading in and out of rather than holding. I've been looking for an entry point but haven't bought back in.
M* has extensive stock ratings / reviews. But doesn't hold a candle to Barron's. M* basically crunches the numbers. Barron's goes a lot deeper considering intangibles, competitors, overall industry health and trends.
5* wide moat: MDLZ, CLX, TRI ( 5-star, wide moat and exemplary capital allocation)
4* wide moat: NOC, CL, BMY, AVGO, OTIS, MSFT
3* wide moat: CAT, V, HON, KO, MRK, SYY
Barron's is "overweight" on HON, CAT, TRI, NOC, CL, OTIS, MDLZ, MRK, SYY with a "buy" on KO, V, AVGO & MSFT.
@hank - Good to know info on Barron's. I take M* ratings with a grain of salt. Mainly, just as a starting point. And because I get it free from T Rowe. I am looking for that intersection of stocks that both Barron's and M* consider "overweight or buy", and that I do not already hold in mutual funds. I also prefer a "wide moat" and "exemplary capital allocation".